Design Therapeutics, Inc. (DSGN) Tops Q4 EPS by 2c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/24/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
| (NASDAQ: DSGN) | Delayed: 10.24 -0.25 (2.38%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $10.49 | 52 Week High | $ | |||
| Open | $10.42 | 52 Week Low | $ | |||
| Day High | $10.42 | P/E | N/A | |||
| Day Low | $10.10 | EPS | $ | |||
| Volume | 210,366 | |||||
